International clinical study and decision of the TJ-SP reinforce the debate on the use of medicinal cannabis in the treatment of fibromyalgia and broaden the discussion on access to cannabidiol in Brazil

Director of Institutional Relations evaluates national cultivation, new RDCs from Anvisa, and the challenges to consolidate the sector in the country

Judicial decision obliges the state government and the municipality of Jaboticaba to cover a treatment cost of $6,000 monthly for a 12-year-old patient, after failure of conventional medications

Court analyzes whether the substance is a medicine or a health product, which directly impacts the funding and access to cannabidiol through the SUS

Unanimous decision of the 3rd Public Law Chamber benefits woman, the rapporteur cites criteria of the STJ

Report indicates 34% annual growth in the sector, driven by legalization and wellness trends

Preclinical study suggests CBD may reduce intestinal spasms and diarrhea, with a direct effect on gastrointestinal motility

Department informed that the inclusion of the treatment in the state protocol is still under technical analysis, with no defined date for the document's completion

Research published in an international journal points to a reduction in controlled medications and behavioral improvements during supervised treatment

Proposal included in the Pluriannual Plan aims to organize access to cannabis-based medications and reduce litigation in the state

The regulatory agency published the decision in the Official Gazette of the Union this Monday (8), allowing the inclusion of the dosage of 300 mg/ml

The Brazilian Association of Pharmaceutical Inputs Industry trusts that the request for a view by director Thiago Campos will result in a more in-depth analysis, maintaining the expectation of concluding the regulatory framework in January 2026

Learn how full spectrum cannabidiol enhances the therapeutic effects of medical cannabis, reduces doses, improves tolerance, and broadens results in chronic pain treatment.

Publication in the Official Gazette of this Monday (8) details the approval of the 100 mg/ml oral solution

Presented at the Brazilian Medicinal Cannabis Congress 2025, the CBD foam facilitates hygiene and treatment of chronic wounds and burns

Draft presents new regulatory framework, tightens requirements for Sanitary Authorization, and prohibits manipulation of cannabis derivatives

Discover how cannabidiol acts in daily life, its effects on well-being, therapeutic applications, and why it has become part of the routine for those seeking more balance

2025 Yearbook shows expansion of treatment, scenario of prescribers, and approximate revenue of R$ 1 billion

Neuropediatrician highlights the potential of full spectrum cannabidiol, but access still faces judicial and bureaucratic barriers

The Health Department of the Federal District has opened a bidding process for the purchase of cannabidiol-based medication, intended for patients with severe epilepsy treated by SUS-DF